Literature DB >> 12297100

Zygotic Wnt activity is required for Brachyury expression in the early Xenopus laevis embryo.

Alin Vonica1, Barry M Gumbiner.   

Abstract

The canonical, beta-catenin-dependent Wnt pathway is a crucial player in the early events of Xenopus development. Dorsal axis formation and mesoderm patterning are accepted effects of this pathway, but the regulation of expression of genes involved in mesoderm specification is not. This conclusion is based largely on the inability of the Wnt pathway to induce mesoderm in animal cap explants. Using injections of inhibitors of canonical Wnt signaling, we demonstrate that expression of the general mesodermal marker Brachyury (Xbra) requires a zygotic, ligand-dependent Wnt activity throughout the marginal zone. Analysis of the Xbra promoter reveals that putative TCF-binding sites mediate Wnt activation, the first sites in this well-studied promoter to which an activation role can be ascribed. However, established mesoderm inducers like eFGF and activin can bypass the Wnt requirement for Xbra expression. Another mesoderm promoting factor, VegT, activates Xbra in a Wnt-dependent manner. We also show that the activin/nodal signaling is necessary for ectopic Xbra induction by the Wnt pathway, but not by VegT. Our data significantly change the understanding of Brachyury regulation in Xenopus, implying the existence of an unknown zygotic Wnt ligand in Spemann's organizer. Since Brachyury is considered to have a major role in mesoderm formation, it is possible that Wnts might play a role in mesoderm specification, in addition to patterning.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297100     DOI: 10.1006/dbio.2002.0786

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  27 in total

Review 1.  T-box genes in early embryogenesis.

Authors:  Chris Showell; Olav Binder; Frank L Conlon
Journal:  Dev Dyn       Date:  2004-01       Impact factor: 3.780

2.  A role for maternal beta-catenin in early mesoderm induction in Xenopus.

Authors:  Anne Schohl; François Fagotto
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

3.  Rap2 is required for Wnt/beta-catenin signaling pathway in Xenopus early development.

Authors:  Sun-Cheol Choi; Jin-Kwan Han
Journal:  EMBO J       Date:  2005-02-10       Impact factor: 11.598

Review 4.  Xenopus as a model system to study transcriptional regulatory networks.

Authors:  Tetsuya Koide; Tadayoshi Hayata; Ken W Y Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

5.  The Xenopus Nieuwkoop center and Spemann-Mangold organizer share molecular components and a requirement for maternal Wnt activity.

Authors:  Alin Vonica; Barry M Gumbiner
Journal:  Dev Biol       Date:  2007-10-02       Impact factor: 3.582

6.  Gtpbp2 is required for BMP signaling and mesoderm patterning in Xenopus embryos.

Authors:  Arif Kirmizitas; William Q Gillis; Haitao Zhu; Gerald H Thomsen
Journal:  Dev Biol       Date:  2014-05-20       Impact factor: 3.582

Review 7.  Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation.

Authors:  Abhirath Parikh; Jincheng Wu; Robert M Blanton; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part B Rev       Date:  2015-05-11       Impact factor: 6.389

8.  FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development.

Authors:  Mario N Chamorro; Donald R Schwartz; Alin Vonica; Ali H Brivanlou; Kathleen R Cho; Harold E Varmus
Journal:  EMBO J       Date:  2004-12-09       Impact factor: 11.598

Review 9.  Tales of Tails (and Trunks): Forming the Posterior Body in Vertebrate Embryos.

Authors:  David Kimelman
Journal:  Curr Top Dev Biol       Date:  2016-01-21       Impact factor: 4.897

10.  Modulation of the beta-catenin signaling pathway by the dishevelled-associated protein Hipk1.

Authors:  Sarah H Louie; Xiao Yong Yang; William H Conrad; Jeanot Muster; Stephane Angers; Randall T Moon; Benjamin N R Cheyette
Journal:  PLoS One       Date:  2009-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.